Semaglutide is the active ingredient in Ozempic®, which is approved by the Food and Drug Administration (FDA) to help people with type 2 diabetes manage their blood sugar levels. Healthcare providers ...

Natco Pharma launches Semaglutide injection in India for type-2 diabetes, with pricing details and brand names announced.

Gastrointestinal tolerability remained the dominant adverse-reaction cluster, aligning with established GLP‑1 receptor ...

This article was reviewed by Darragh O’Carroll, MD. Common semaglutide side effects include nausea, vomiting, diarrhea, and constipation. These should get better with time. Avoid fatty and greasy ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Nausea is the most common side effect of semaglutide, the weight loss and diabetes medication sold under the brand names Ozempic and ...

Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg has shown promising results in early-phase trials; the efficacy of the ...

Semaglutide, available under the brand names Ozempic, Wegovy, and the oral tablet Rybelsus, is effective for diabetes and weight management, but like any medication, it may have some side effects.

India’s semaglutide patent expiry has triggered a wave of cheaper generic versions of Ozempic, slashing prices and expanding ...

Cagrilintide and semaglutide have each been shown to induce weight loss as monotherapies. Data are needed on the coadministration of cagrilintide and semaglutide (called CagriSema) for weight ...

Please provide your email address to receive an email when new articles are posted on . In patients with type 2 diabetes, CagriSema lowered HbA1c to a greater degree than semaglutide at 68 weeks.

The generic versions of semaglutide are expected to be at least 50% cheaper— ₹5,000 for a weekly dose—than Ozempic in India .